RecallRadar

FDA Drug recall D-389-2013

Methylprednisolone and Dexamethasone Injection, all strengths and all presentations including a) Methylpred/ Dexameth 1-2-3 mL and b) Methy…

On 2013-05-22 the FDA classified a Class II recall of Methylprednisolone and Dexamethasone Injection, all strengths and all presentations including a) Methylpred/ Dexameth 1-2-3 mL and b) Methy… by Fvs Holdings Dba Green Valley Drugs, citing lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associate….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-389-2013
ClassificationClass II
Statusterminated
Initiated2013-04-10
Published2013-05-22
Last updated2026-09-13 11:51 UTC
CompanyFvs Holdings Dba Green Valley Drugs
DistributionUS

Product

Methylprednisolone and Dexamethasone Injection, all strengths and all presentations including a) Methylpred/ Dexameth 1-2-3 mL and b) Methylpred/Dexa 3 mL PFS; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

Reason

Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Identifiers

code_infoLot #: a) Methylpred/ Dexameth 1-2-3 mL: 13040150GV1, Exp 7/1/2013; 13032750GV3, Exp 6/27/2013; b) Methylpred/Dexa 3 mL PFS: 13032050GV4, Exp 6/20/2013

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-389-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.